tiprankstipranks
pc:vorbi

Vor Bio

Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$150M
Total Amount Raised$150M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$150M
Latest Funding Amount$150M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Dec 15, 2025
Investment
$150.00M

Investors

Investor Name
Funding Round

Related News and Analysis